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Abstract. We have developed specific antibodies to
synthetic peptide antigens that react with the in-
dividual subunits of casein kinase 11 (CKII) . Using
these antibodies, we studied the localization of CKII
in asynchronous HeLa cells by immunofluorescence
and immunoelectron microscopy. Further studies were
done on HeLa cells arrested at the Gl/S transition by
hydroxyurea treatment. Our results indicate that the
CKII a and ß subunits are localized in the cytoplasm
C
ASEIN kinase II (CKII)' is a ubiquitous protein ser-
lne/threonine kinase found in eukaryotic cells (Edel-
man et al .
￿
1987 and highly conserved among eu-
karyotic organisms, including Drosophila, yeast, C. elegans,
bovine, and human (Saxena et al ., 1987; Chen-Wu et al.,
1988; Hu and Rubin, 1990a ; Lozeman, 1990). Casein ki-
nase II from several species share a common polypeptide
subunit structure, a2ß2, with a of M 37,000-44,000 and ß
of M 24,000-28,000 by electrophoresis (Edelman et al.,
1987) . Two forms of a are known designated a (M
41,000-44,000) and a' (M, 37,000-42,000). The a and a'
subunits are thought to be the catalytic subunits based on
their kinase activity in the absence of the ß subunit and se-
quences common to other protein kinases (Hathaway et al .,
1981; Cochet and Chambaz, 1983 ; Chen-wu et al ., 1988 ;
Meisner et al., 1989; Hu and Rubin ; 1990a). The function
of the ß subunit is unknown, and it shares no extensive ho-
mology to other known protein sequences (Jakobi et al .,
1989) . The ß subunit has a high degree of polarity with
clusters ofnegative charges in the amino-terminal region and
positive charge clusters in the carboxy-terminal region
(Takio et al., 1987) . The basic compounds, spermine, sper-
midine, and polylysine, stimulate activity by interacting at
least in part with the ß subunit (Traugh et al ., 1990). This
subunit may have a regulatory role in the holoenzyme (Takio
et al., 1987), and evidence supporting this has been found
in A-431 cells (Ackerman et al., 1990). The comparative
studies using the native CKII holoenzyme and the bacterially
expressed a subunit show that the expressed a is inhibited
by heparin, but it is not stimulated by polyamines and has
9% of K t of the holoenzyme (Hu and Rubin, 1990b) . This
1. Abbreviation used in this paper: CKII, casein kinase 11.
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during interphase and are distributed throughout the
cell during mitosis. Further electron microscopic in-
vestigation revealed that CKII a subunit is associated
with spindle fibers during metaphase and anaphase. In
contrast, the CKII a' subunit is localized in the nu-
cleus during GI and in the cytoplasm during S. Taken
together, our results suggest that CKII may play sig-
nificant roles in cell division control by shifting its lo-
calization between the cytoplasm and nucleus.
further suggests that CKII holoenzyme is stabilized by inter-
action with the ß subunit.
The structures of cDNA clones for human CKII a and a'
have been determined, and the molecular weights of the a
and a' predicted from the human cDNAs were 45,160 and
41,450, respectively (Lozeman et al., 1990). The amino acid
sequence of the ß subunit was initially derived by sequencing
the isolated subunit from bovine lung (Takio et al ., 1987),
and the human CKII ß cDNA has been isolated as well, giv-
ing the predicted molecular weight of 24,925 (Jakobi et al.,
1989) .
The enzyme has a variety of known substrates, includ-
ing enzymes, cytoskeletal proteins, transcription factors, a
phosphatase inhibitor, and oncoproteins (Table 1) . The sub-
strate specificity of CKII is for serine or threonine residues
aminoterminal to acidic amino acids (Meggio et al., 1984;
Kuenzel et al ., 1987) . The enzyme has been shown to be ac-
tivated following the addition ofgrowth factors, such as insu-
lin and epidermal growth factor, or serum to cells (Sommer-
corn et al., 1987; Klarlund and Czech, 1988; Carroll and
Marshak, 1989). It is also induced during differentiation of
3T3-Ll cellsinto adipocytes (Sommercorn and Krebs, 1987).
CKII or a similar enzymatic activity has been identified
in both the cytoplasm and nucleus of mammalian cells
(Hathaway and Traugh, 1982). In rat liver, CKII activity is
predominantly (90%) cytosolic, with the remaining activity
divided among the nuclear, mitochondrial, and microsomal
fractions (Singh and Huang, 1985; Edelman et al., 1987).
However, in Rana temporaria oocytes, the enzyme is found
exclusively in the cytoplasm (Kandror et al., 1989). The
CKII activity purified from nuclei has similar characteristics
to those used to define cytoplasmic CKII (Edelman et al .,
1987), including (a) cAMP independence; (b) similar KmsTableI. Selected Substrates of CKII
Enzymes
￿
DNA topoisomerase II (Ackerman et al., 1985)
RNA polymerase I and II (Stetler and Rose,
1982)
Glycogen synthase (Picton et al., 1982)
DNA polymerase a (Podust et al., 1990)
Ornithine decarboxylase (Peng and Richards,
1988)
Cytoskeletal
￿
Tubulin (Serrano et al., 1987; Diaz-Nido et al.,
proteins 1990x)
Brain myosin heavy chain (Murakami et al.,
1990)
MAP-lA, MAP-1B (Diaz-Nido et al., 1988)
Clathrin (Cantournet et al., 1987)
Transcription
￿
Serum response factor (Manak et al., 1990)
factors
Oncoproteins
￿
Myc and Myb (Luscher et al., 1989, 1990)
SV40 large T antigen (Grisser et al., 1988)
Other
￿
Nucleolin (Schneider and Issinger, 1988)
cAMP-regulated phosphoprotein (Girault et al.,
1989)
for ATP and GTP as phosphate donors; (c) inhibition by
heparin; and (d) stimulation by polyamines (Thornburg et
al., 1979; Matthews and Huebner, 1984). Nucleolus-asso-
ciated CKII has been identified, has been shown to phos-
phorylate nucleolin as a substrate, and may be involved in
ribosome assembly (Caizergues-Ferrer et al ., 1987; Schnei-
derandIssinger, 1988)andregulation ofrDNA transcription
(Belenguer et al., 1989).
The distribution of the subunits of CKII between the nu-
cleus andcytoplasmis notknown. In fact, the exactsubcellu-
lar location of the subunits of CKII (ca, ca', and R), thedistri-
bution of the holoenzyme, and the regulation of these
subunits arealso unknown. Severallocalization studies have
been done by subcellular fractionation (Thornburg et al .,
1979; Singh andHuang 1985 ; Hathaway and Traugh, 1982;
Filhol et al., 1990). Such studies involve isolating subcellu-
lar fractions by differential centrifugation and subsequent
measurement of their CKII activity. It is difficult to assess
whether CKII activity arises from asingle subunitor acom-
bination of subunits. In addition, these studies have not ad-
dressedthe localization ofthe enzyme during specific stages
of the cell division cycle.
Immunocytochemical localization studies using antibod-
ies against holoenzyme have been published (Pfaff and An-
derer, 1988; Serrano et al., 1989; Belenguer et al., 1989;
Filhol et al ., 1990). CKII was detected by inununocyto-
chemistry in the cytoplasm, nuclei, and nucleoli of growing
cells, while it was no longer presentin nucleoli of confluent
cellsof adultaortic endothelial cells (Belenguer et al., 1989).
In addition, the distribution of CKII exhibited a shift toward
an increased nuclear concentration during active prolifera-
tion ofbovine adrenocortical cells in primary culture (Filhol
et al ., 1990). Furthermore, CKII is localized to some micro-
tubule arrays in neuronal and nonneuronal cells. This local-
ization is to microtubule bundles within the mitotic spindle
of dividing cells and within the neurites of differentiating
neuroblastoma cells (Serrano et al., 1989). Immunohisto-
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chemical localization studies using antibodies against holo-
enzyme do not specify the localization and interaction of
CKII subunits. Thus, thedevelopmentof specific antibodies
againstCKII subunits andtheir localization by immunocyto-
chemistry is necessary to further address the role of CKII
during cell growth anddifferentiation. In addition, the local-
ization of CKII subunits will help to identify potential roles
for CKII during the cell cycle.
In this report, we describe thedevelopmentof specific an-
tibodies to syntheticpeptidesubstrates representing epitopes
on CKII a, et', and /3 subunits. These reagents were used to
investigate thelocalization of CKII in asynchronous andsyn-
chronous cellsusingsubunit-specific antibodies. Ourcurrent
studies of CKII localization using immunocytochemistry
andEM indicate that theCKII a and(3 subunits arepredomi-
nantly localized in the cytoplasm, while the localization of
the a' subunit is nuclear and appears to be regulated during
the cell cycle. Finally, our results also suggest that there is
translocation of CKII between thenucleusandthe cytoplasm
in S phase of the cell cycle.
Materials andMethods
Cells
HeLacellswere grown in 24-wellculture dishes containing 12-mmcircular
glass coverslips in DME supplemented with 1% (wt/vol) penicillin and
streptomycin,and5%(vol/vol) FBSat 37°C. Forcell division cycleexperi-
ments, HeLa cells were exposed to 1.5 mM hydroxyurea (Sigma Chemical
Co., St. Louis, MO) for 14 h to arrest cells at theGl/S transition (Ashihara
and Baserga, 1979). Furthermore, thearrested cells were allowedto pro-
ceed through theircell cycleby removing thehydroxyurea andby resupply-
ing fresh medium.
Synthetic Peptides
Peptides, CSH 118 RRREEETEEE; CSH 122 acetyl-SGPVPSRARVYT
DVNTHRPREC (2-22 of CKII a); CSH 123CVVKILKPVKKKKIKREI-
KILE (65-86 of CKII a and66-87 of CKII a'); CSH 124 HSENQHLVS-
PEALDFLDKLLRYDHQC (286-310 of CKII a and 287-311 a'); CSH
125 CMDVYTPKSSRHHHTDGAYFGTG (140-162 of CKII S) were syn-
thesized by solidphasemethods(BaranyandMerrifield, 1979)on p-methyl-
benzylhydrylamine polystyrene resin using pre-formed, symmetric anhy-
drides and hydroxybenzotriazole-activated esters of N-cr-Boc protected
amino acids on an automated peptide synthesizer (model 430A; Applied
Biosystems Inc., Foster City, CA). Couplingswere done in dimethylforma-
mide and dichloromethane as solvents, and unreacted peptidewas capped
with acetic anhydride. Theside chain-protectedamino acidswere: serine-
O-benzyl; glutamyl-y-O-benzyl ester, aspartyl-/3-O-cyclohexyl ester;N-a-
benzyloxycarbonyl histidine; NgTosylarginine; andO-2-bromobenzyloxy-
carbonyl tyrosine. Thepeptidesweredeprotected andcleavedfromtheresin
with liquid HF at -10°C for 2 h in the presence of 5% (vol/vol) anisole
and5% (vol/vol) dimethyl sulfide. Thepeptidewasprecipitated with ethyl
ether, and solubilized in 0.1% (wt/vol) aqueous trifluoroacetic acid. The
solution wassubjectedto HPLC usi aWaters DeltaPrep 3000 instrument
on a column (4.9 x 30 cm) of 30o nA, Cis silica (Waters Division, Milli-
pore Corp., Milford, MA)andelutedwith 0.1% (wt/vol)trifluoroaceticacid
with a linear gradient of acetonitrile (Burdick and Jackson Laboratories,
Muskegon, MI ). The peptide was further purified by HPLC on acolumn
(2.2 x 25 cm) of silica using C,s-bonded, 300A pore size silica, 10 Am
in diameter (Vydac,TheSeparations Group, Hesperia, CA). Thestructure
of thefinalpeptidewasverified by aminoacid analysis, automatedsequence
analysis, plasma desorption mass spectrometry, and analytical microbore
HPLC as described (Marshak and Carroll, 1991).
Antibody Preparation
Thepeptides, CSH 122, 123, 124, and 125 were coupled to keyhole limpet
hemocyanin (Sigma Chemical Co.)or ovalbumin(SigmaChemical Co.) via
maleimidobenzoyl-N-hydroxysuccinimide (Pierce Chemical Co., Rock-
1218ford, IL) as described (Harlow and Lane, 1988) . Antisera against the com-
plexes were raised as follows . The complexes (0.5 mg) in 0 .5 ml of PBS was
mixed with 0.5 ml of Freund's complete adjuvant and injected subcutane-
ously. Booster injections were given with incomplete adjuvant at2-wk inter-
vals. Additional booster injections were given at 2-wk intervals until reach-
ing maximum serum titer. Serum antibody titer was determined by RIA .
Wells of 96-well polyvinylchloride microliter plates were coated with
purified CKII . The plates were washed and unbound sites were saturated
with 3% (wt/vol) BSA . Dilutions of immune and preimmune serum were
added to wells. The plates were washed with PBS and 50,000 cpm of 125I-
labeled goat anti-rabbit IgG F (ab)'2 added per well . After washing, the
specific activity ofeach serum sample was determined by measuring radio-
activity in a gamma radiation counter (LKB Instruments, Gaithersburg,
MD) . Immune rabbit IgGs were prepared using a ProteinG orA Sepharose
column (Pharmacia Fine Chemicals, Piscataway, NJ) according to the
instructions of the manufacturer. Affinity-purified TRITC-labeled goat
anti-rabbit IgG was purchased from Cappel Laboratories (Malvern, PA) .
245 Ab wasfurther purified usingaCNBr-activated Sephadexcolumn (Phar-
macia Fine Chemicals) containing bound peptide CSH 122 .
ProteinKinase Assay
The peptide RRREEETEEE (CSH 118) was used as a CKII-specific sub-
strate (Kuenzel and Krebs, 1985) . Protein kinase activity was assayed as de-
scribed (Carroll and Marshak, 1989) . Briefly, CKII activity was determined
by measuring the incorporation of32p into CKII-specific peptide substrate,
as follows . Samples (5 A1) were incubated in a final volumeof 30Al at 37°C
for 30 min in the presence of 20mM Hepes, pH 7.4, 10 MM M9C12 , 100
AM 1y- 32P]ATP (1,000-3,000 cpm/pmol, Amersham Corp ., Arlington
Heights, IL) with 5mM peptide. Reactions were started by adding radioac-
tive ATP. Assays using the peptide RRREEETEEE were stopped by adding
TCA to a final concentration of 10% (wt/vol), and phosphate incorporation
was determined by adsorption to phosphocellulose paper according to pre-
viously described protocols (Kuenzel and Krebs, 1985 ; Marshak and Car-
roll, 1991) .
Purification ofCKIIfrom BovineBrain andLiver
Fresh bovine brain or liver (-1,500 g) was homogenized in 3 L of buffer
A (20mM Tris-Cl, pH 7.4, 10mM EGTA, 2 mM EDTA, 0.5 mM PMSF,
1 mM DTT, and 10% (vol/vol) glycerol). The homogenates were cen-
trifuged at 11,000 g, 4°C for 1 h . Then supernatants were collected and
diluted in buffer A to a conductivity less than 2 mS/cm . The supernatants
were mixed with 250 g of diethylaminoethyl cellulose (Whatman DE-52)
for 2 h . The resin was then washed through a Buchner glass funnel with
5 liters of Buffer A containing 10 MM MgC12 . The washed resin was
packed into a 5 x 40-cm column, and a gradient of a total of 2,000 ml of
KCI (50-400 mM) in bufferA containing 10MM MgC12 eluted the column
at a rate of 100 ml/h, 15 ml per fraction . Every third fraction was assayed
for CKII activity. The active fractions were pooled and applied to a 100-ml
(2 .5 x 20 cm) phosphocellulose (Whatman PI 1) column previously
equilibrated with buffer A containing 10 MM MgC12 and 400 mM KCI .
After washing the Pll column with the equilibration buffer, proteins were
eluted with a gradient of 500 ml of KCI (400-1,000 mM) in buffer A con-
taining 10 MM MgC12 . The fractions were assayed for CKII activity and
the active fractions were pooled . This pool was diluted with bufferA to a
conductivity equaltothat ofbufferA containing 300mM KCI . The solution
was applied to a hydroxyapatite (BioRad HTP; Bio-Rad Laboratories, Rich-
mond, CA) column equilibrated in buffer A containing 300mM KCI . The
column was washed with buffer A containing 50 mM KCI, and the CKII
was eluted with a gradient of500 ml potassium phosphate (0-300 mm, pH
7.9) buffer. The fractions were assayed for CKII activity and the active frac-
tions were pooled . Finally, the pooled solution was applied to a column of
heparin-Sepharose CL-6B (Pharmacia Fine Chemicals) equilibrated in
buffer A . CKII was eluted with a gradient of 50 in] KCI (0-800 mM) in
bufferA . The fractions were assayed for CKII activity and the active frac-
tions werepooled and stored at -70°C. Electrophoretic analysis ofthis ma-
terial revealed homogeneous CKII containing a, a', and 0 subunits as de-
scribed (Hathaway and Traugh, 1982 ; Kuenzel and Krebs, 1985) .
GelElectrophoresis andImmunoblotting
Electrophoresis was performed on 12 .5% (wt/vol) polyacrylamide gels in
the presence of SDS using the buffer system of Laemmli (1970) . Proteins
were transferred electrophoretically to nitrocellulose (Towbin et al ., 1979 ;
Towbin and Kurstak, 1984) . The nitrocellulose was blocked with 3% BSA
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(wt/vol) in PBS and then incubated with antiserum at desired dilutions in
the same buffer.
í 25I-labeled goat anti-rabbit IgG F(ab)2 was used as sec-
ondary antibody. The gels were stained with Coomassie blue, dried and ex-
posed to film (Kodak X-Omat) .
Flow Cytometry
Flow cytometric analysis was done as described by Buchkovich et al .
(1989) . Cells (5 x 106) were washed and resuspended in 0.5 ml ofice-cold
PBS. The cells were fixed by gradual addition of 95% ethanol (-20°C)
while vortexing. The fixed cells were washed with PBS and resuspended in
1 ml ofPBS containing 10 pg/ml boiled RNAase A (Sigma Chemical Co.)
and 5 pg/ml of propidium iodide . After a 30-min digestion and staining
period at 37°C, the fluorescence intensities of the samples were measured
by quantitative flow cytometry using an EPICS C system (Coulter Elec-
tronics Inc ., Hialeah, FL) .
Indirect Immunofiuorescence
Indirect immunofluorescence was performed as described by Spector and
Smith (1986) . Cells (105 ) grown on glass coverslips (12 mm) or mitotic
cells attached onto poly-L-lysine-coated glass coverslips were fixed with
4% paraformaldehyde in PBS. Cells were permeabilized with 0.2% Triton
X-100 on ice in PBS containing 0.5% normal goat serum and reacted with
respective primary antibodies for 1 h. Bound antibodies were detected with
rhodamine conjugated goat anti-rabbit secondary antibody (Cappel Labora-
tories) . Thecells were stained with affinity-purified TRITCgoat anti-rabbit
IgG . Samples were examined with a Zeiss Axiophot microscope equipped
with epifluorescence illumination (Carl Zeiss Inc ., Thomwood, NY) .
Immunoelectron Microscopy
Cells were fixed in 2% formaldehyde plus 0.1% glutaraldehyde or withjust
0.5 % glutaraldehyde for 15 min at 20°C and prepared for immunoelectron
microscopy according to published procedures (Spector, 1984 ; Spector and
Smith, 1986) . Briefly, fixed cells were washed in 0.5 mg/ml sodium borohy-
dride, permeabilized in 0.2% Triton X-100 and washed in PBS, pH 7.4, con-
taining 1% normal goat serum before incubation in the specific purified IgG
at a concentration of 100 pg/ml or the corresponding preimmune IgG for
1 h at 20°C. Cells were then extensively washed in PBS and incubated in
peroxidase-conjugated secondary antibody at a dilution of 1:20 for 1 h at
37°C. The peroxidase reaction product was developed by incubation in 0.5
mg/nil DAB containing 0.01% H202 for 20 min at 20°C . Cells were then
fixed in 2% osmium tetroxide and prepared for EM by standard methods
(Spector and Smith, 1986) . Thin sections (100 nm) cut on a Reichert
Ultracut E ultramicrotome with a Diatome diamond knife were examined
with a Hitachi H-7000 transmission electron microscope operated at 75 kV .
Results
DevelopmentofAntibodies to Peptides
CKII activity has been found in both the nucleus and
cytoplasm, and the enzyme has been implicated in the cell
division cycle and in hormonal stimulation of cell growth .
Substrates for the enzyme are found both in the cytosol and
nucleus . To learn how the enzyme is regulated during cell
growth, it appeared necessary to localize CKII within the
cell . Because of its ubiquitous nature and highly conserved
structure, our numerous attempts to obtain antibodies
against the intact holoenzyme have not been successful .
Therefore, we adopted the strategy of using synthetic pep-
tides as antigens which allow us to prepare several site-
directed antibodies to individual subunits of CKII .
Synthetic peptides were designed to encompass three
regions of CKII a and one of CKII ß subunits (Fig . 1), con-
taining amino acid sequences that are highly conserved
among species . These regions consist of predominantly po-
lar and charged residues, and are likely to lie on the surface
of the proteins in solution (Rose et al ., 1985) . Such hydrated
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Figure 1 . Sequences of synthetic peptides in CKII . The sequences
ofCKII aanda subunits were deduced from human cDNA clones
by Lozeman et al . (1990) . The sequence of CKII 0 subunit was de-
rived from human cDNA from HeLa cell by Jakobi et al . (1989) .
The shaded boxes represent the residues corresponding to the
respective synthetic peptide .
Table H. Polyclonal Antisera Raised Against
Synthetic Peptides
regions arethought to be highly antigenic (Hopp and Woods,
1981).
As shown in Fig . 1 and Table II, antibody (Ab) 245 was
raised by immunizing rabbits with peptide CSH 122, which
represents aunique sequence at the amino terminus of CKII
a (2-22) . The methionine initiator was not included andthe
peptide was acetylated, because the amino terminus of a is
blocked to Edmandegradation . Thepeptidecontained a cys-
teine at the carboxy terminus so it would be oriented
properly on coupling . Ab 247 was raised by using peptide
CSH 123 whichcontains an internal CKII cda'sequence that
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Figure2 . Titration of immune serumto purified CKII . Serum anti-
body titer was determined by RIA . Wells of 96-well polyvinyl mi-
crotiter plates were coated with purified CKII . Dilutions of immune
and preimmune serum (open circles) were added to wells . The
plates were washed with PBS and 125I-labeled goat anti-rabbit IgG
F (ab)'2 added per well . After washing the titer of serum was de-
termined by measuring radioactivity in a gamma counter. Results
represent the means of experiments in duplicates . A, Ab 245 ; B,
Ab 247; C, Ab 276 ; D, Ab 278.
Figure 3 . Immunoblotting of peptide antibodies to purified bovine
liver CKII . Purified bovine liver CKII was subjected to electropho-
resis on 12.5% polyacrylamide gel, transferred to nitrocellulose,
and probed with peptide antibodies . Ab 245 specific fora (lane 2),
Ab 247 (lane 3) and 276 (lane 4) for a anda and Ab 278 (lane
5) for 0 . The C'4-labeled molecular masses (in kilodaltons) of
marker proteins are shown at the left (lane 1) and lane 6 . Phos-
phorylase b (M 92,500), BSA (M, 69,000), ovalbumin (M
46,000), carbonic anhydrase (M, 30,000), and trypsin inhibitor
(M, 21,500) . Coomassie staining ofthe molecular marker proteins
andCKII a, a and0 was shown in lane 6 and lane 7, respectively.
The relative migration of the a, a, and 0 subunits of bovine CKII
are shown at the right (arrowheads) .
is similar to a nuclear localization signal (bang and Lee,
1989) and is common to both a and a' (Fig . 1) . Ab 276 was
raised againstCSH 124 which spans sequences near the car-
boxy terminus and shares common sequence for a and a' .
Finally, Ab 278 was raised by injecting CSH 125 conjugates
that containa sequence of ß (140-162) . All of these peptides
were conjugated to carrier proteins (keyhole limpet hemo-
cyanin or ovalbumin) andthe conjugates were used to immu-
nize rabbits as described under Materials and Methods .
Dilutions of the sera were tested for their ability to detect
purified bovine liver or brain CKII on solid phase RIA. All
Figure 4 . Immunoblotting of peptide antibodies to HeLa cell ex-
tracts . HeLa cell extracts were subjected to electrophoresis on
12.5% polyacrylamide gel, transferred to nitrocellulose, and
probed with peptide antibodies . Ab 245 specific fora (lane 2), Ab
247 (lane 3) and 276 (lane 4) for a and ot, Ab 278 (lane 5)
for0. TheC' 4-labeled molecularmasses (in kilodaltons) of marker
proteins are shown at the left (lane 1) . Phosphorylase b (M
92,500), BSA (M 69,000), ovalbumin (M 46,000), carbonic an-
hydrase (M 30,000), and trypsin inhibitor (M r 21,500). The rela-
tive migrationofthe a,a; and 0 subunits ofbovine CKII areshown
at the right (arrowheads) .
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Peptide
Antigen Specificity
Ab 245 CSH 122 CKII a
Ab 247 CSH 123 CKIIa&á
Ab 276 CSH 124 CKIIa&á
Ab 278 CSH 125 CKII 0Figure 5. Flowcytometric pro-
files of asynchronous HeLa
cells. Asynchronous HeLacells
were harvested, and then fixed
in ethanol and stained for flow
cytometry analysis . The open
and closed triangles mark 2N
and4N DNA content, respec-
tively.
the sera reacted with purified CKII and had >1:1,000 titer in
this assay, indicating antibody reactivity to native CKII mol-
ecules (Fig . 2) . All the sera reacted positively with CKII on
immunoblots after polyacrylamide gel electrophoresis of the
purified enzyme, demonstrating that the antibodies react
with denatured CKII molecules as well . In control experi-
ments, interactions between the antisera and CKII enzyme
could be blocked by incubation with excess free peptides
(data not shown) . Ab 245 reacted to CKII a (M 42,000)
exclusively (Fig . 3, lane 2), while Ab 247 and 276 reacted
with both CKII a and a' (M 39,000) (Fig . 3, lanes 3 and 4)
Ab 278 reacted with CKII ß (M 29,000) (Fig . 3, lane 5) .
All of the immunoreactive bands comigrated with the corre-
sponding band of purified CKII a, a', or ß visualized by
Coomassie blue staining (Fig . 3, lane 7) . The antibodies
were further characterized by immunoblotting of HeLa cell
lysates to test whether they are specific for CKII . Ab 245
only reacted to CKII a (M 46,700) (Fig . 4, lane 2), while
Ab 247 and 276 reacted with both CKII a and a' (M
42,600) (Fig . 4, lanes 3 and 4) . Ab 278 reacted with CKII
ß (M 27,000) (Fig . 4, lane 5) . No other immunoreactive
proteins were detected . These antibodies thus provided spe-
cific reagents to examine the subcellular localization of
CKII .
Localization ofCKII inAsynchronousHeLa Cells
In this studywe have used the antibodies characterized above
to localize CKII in HeLa cells by immunocytochemistry.
Asynchronous HeLa cells consisted ofa cell population 52.8
t 6.2% of Gl, 18 .1 f 2 .6% of S, and 22 .8 f 3.0% ofG2/M
by FACS analysis based on an average offive separate experi-
ments . One example of the FACS analysis is shown in Fig .
5 . The open and closed triangles designate 2N and4N DNA
content, respectively.
These cells were fixed, permeabilized, and stained with
antibodies described above to a, a', and ß . The immuno-
staining pattern was visualized by indirect immunofluores-
cence using rhodamine-conjugated secondary antibodies .
Cells stained withAb 245, which specifically recognizes the
a subunit, showed predominant localization to the cytoplasm
(Fig . 6, C and D) . The staining intensity of the nucleus is
very low to negative as compared to the cytoplasmic stain-
ing. The staining is absent in vacuoles and on the plasma
membrane. In contrast to Ab 245, Abs 247 and 276, which
recognize the a andá subunits, stained both the cytoplasm
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and nucleus of -80% of the cell population (Fig . 6, E-H),
the other 20% ofthe cells were negative for nuclear staining .
The ß subunit-specific antibody, Ab 278, stained the cyto-
plasm (Fig. 6, 1 and J) similar to Ab 245 ; however, nuclei
were not stained . The immunofluorescence of subunit-spe-
cific antibodies is blocked by their respective peptides (data
not shown) . From these results, it appears that CKII a and
ß are mainly localized to the cytoplasm in asynchronously
growing cells . CKII a', however, appears to be localized to
the nucleus and possibly to the cytoplasm . The negative nu-
clear stainingpattern apparent in-20% of the cells immuno-
stained with Ab 247 and 276, which both recognize theá
subunit of CKII, suggested that the localization of CKII a'
may be regulated as a cell cycle-dependent phenomenon .
Localization ofCKII by Immunoelectron Microscopy
To further identify the subcellular localization of CKII, im-
munoelectron microscopic studies were performed on asyn-
chronous HeLa cells . As shown in Fig . 7, cells immuno-
stained with Ab 245 showed exclusive cytoplasmic staining
(Fig . 7 B) compared to control cells incubated inpreimmune
IgG followed by peroxidase-conjugated secondary antibody
(Fig . 7 A) . The EM study also revealed that the ß subunit-
specific antibody, Ab 278, immunostained the cytoplasm and
showed little to no nuclear immunoreactivity (Fig . 7 C) .
These findings further confirm the immunofluorescence
staining pattern observed and our notion that CKII a and ß
subunits are localized to the cytoplasm of interphase cells .
In contrast to Ab 245 and Ab 278, the a- and ae'-specific Abs
247 and 276 stained both the cytoplasm and nucleus by im-
munoelectron microscopy (Fig . 8,A and B) . It is also notable
that some cells are nuclear negative for both Ab 247 and 276.
These findings support our initial immunofluorescence re-
sults (Fig . 6), reinforcing the idea that CKII a' is localized
to the nucleus and, possibly, cytoplasm, and that a' staining
is more intense in the nucleus than a staining .
Localization ofCKII in HeLa Cells In Mitotic Cells
The results of CKII localization obtained using asynchro-
nous cells did not provide us with enough information about
the regulation ofdistribution of CKII during the cell division
cycle . In addition, the roles of CKII in cellular regulation
that involve ubiquitous and multiple phosphorylation reac-
tions, in both the cytoplasm and nucleus, needed to be inves-
tigated in synchronous cell populations to clarify the actual
distribution of CKII in each phase of the cell cycle.
Since mitotic cells are round and loosely attached to the
growing surface, it was difficult to precisely assess the local-
ization of CKII by immunofluorescence microscopy. There-
fore, electron microscopic investigations were done tomore
fully elucidate the localization ofCKII during mitosis .
Examples of the electron microscopic analysis of mitotic
cells are shown in Fig. 9. Fig . 9 a shows a cell at metaphase,
when the chromosomes become aligned at the metaphase
plate half-way between the spindle poles . Fig . 9 c shows a
cell in anaphase in which each pair of chromosomes has
separated and movement to opposite poles has begun . In
these micrographs, CKII a is diffusely localized (Ab 245)
throughout the cytoplasm . It is notable, however, that there
is very strong staining, compared to the control (Fig . 9 d),
associated with spindle fibers (Fig . 9, arrowheads) whose
122 1The Journal of Cell Biology, Volume 114, 1991
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Figure 6. CKII u, a, and /3 immunofluores-
cence in asynchronous HeLa cells . HeLa cells
were fixed and stained as described in Mate-
rials andMethods using purified IgG of preim-
mune (A and B) ; Ab 245 (C and D) ; Ab 247
(E and F) ; Ab 276 (G and H) ; and Ab 278 (I
and J) . Bar, 20 ym .Yu et al . Immunocytochemical Localization of Casein Kinase 11
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Figure 7 . Immunoelectron microscopic analysis of
asynchronous HeLa cells . HeLa cells were im-
munostained as described by using preimmune
IgG (a) ; Ab 245 (b) ; andAb 278 (c) . Note the im-
munoreactivity is predominantly in cytoplasm
(C), not in nuclei (N) or nucleoli (Nu) compared
to the control.Figure 8 . Immunoelectron microscopic analysis of asynchronous HeLa cells. HeLa cells were stained with Ab 247 (a) and Ab 276 (b).
The immunoreactivity is present in either cytoplasm (C) exclusively or cytoplasm and nucleus (N) .
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1224Figure9 . Immunoelectron microscopic analysis ofmitoticHeLacells.HeLa cells in metaphase (a, b, andd) andanaphase (c) were stained
with Ab 245 (a-c' or preimmune IgG (d) . The photograph in b is ahigher magnification of that in a . Note the diffuse cytoplasmic im-
munoreactivity and very strong staining of spindle fibers (arrowheads) .
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1225Figure 10. CKII a, and 0 immunofluorescence in hydroxyurea-treated HeLa cells . HeLa cells grown on 12-mm coverslips in 24-well tissue
culture dishes were treated with hydroxyurea for 18 h . HeLa cells were fixed and stained as described in Materials and Methods using
Ab 245 (A and B), Ab 278 (C and D) . Bar, 20 pm .
majorcomponent is tubulin . Fig . 9 b is a high magnification
view showing the intense immunostaining of microtubules
and the negative staining of thechromosomes. The intensity
ofthe control (Fig . 9 d) was so weak that the negative needed
four times longer exposure than experimental samples to
visualize, thus indicating the specificity of the cytoplasmic
and microtubule staining. In addition, the microtubules are
present in the control section but hardly recognizable (ar-
rowheads), indicating that the antibodies have substantial re-
activity to microtubules or microtubule-associated proteins
in the immunostained samples . The chromosomes them-
selves are not stained with anti-CKII a subunit antibody
(Fig . 9, a-d) . It is likely, therefore, that CKII is associated
with microtubules in mitotic cells, and may be an integral
part of the mitotic apparatus .
The Journal of Cell Biology, Volume 114, 1991
Localization ofCKII inSynchronousHeLa Cells
To study cellular localization of CKII in synchronous cells,
HeLa cells were exposed to 1.5 mM hydroxyurea for 14 h
to arrest cells at the Gl/S transition (Ashihara and Baserga,
1979) . The results ofFACS analysis indicated that >70% of
the cells are in Gl/S transition, whose DNA content was in-
termediate between 2N and 4N within 4 h after release . As
shown in Fig. 10 (A and B), the staining pattern of hy-
droxyurea-treated cells stained withAb 245 showed predom-
inant staining of the cytoplasm as seen in asynchronous cells.
The cytoplasmic staining is again absent in vacuoles and on
the plasma membrane . Theß subunit-specific antibody, Ab
278, exhibits cytoplasmic staining with little to no nuclear
immunoreactivity (Fig . 10, C and D) . The a and a'-specific
1226Figure 11. FACS analysis ofhydroxyurea arrest released HeLa cells .
Asynchronous HeLa cells arrested by hydroxyurea for 14 h were
washed and incubated with new medium . Samples were collected
every 4 h and processed for FACS analysis. A, asynchronous HeLa
cells; B, 0 h after release ; C, 4 h ; D, 8 h ; E, 12 h; F, 16 h ; G, 20 h ;
H, 24 h after release . The open and closed triangles mark 2N and
4 N DNA content, respectively .
Ab 276 stained both cytoplasm and nucleus. However, in
HeLa cells arrested by hydroxyurea, the percent of nuclear
positive forAb 276 increased slightly from 86 to 94 %, based
on analysis of>500 cells in each sample. The staining byAb
247 to hydroxyurea-arrested cells appeared indistinguish-
able from the pattern seen for Ab 276 (data not shown) .
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These results further suggested that the expression of CKII
a' might be regulated in a cell cycle-dependent manner.
To substantiate the findings, the HeLa cells arrested by
hydroxyurea were released by washing out the hydroxyurea
and by adding fresh culture medium . Samples were taken at
time points from 0 h to 4, 8, 12, 16, 20, and 24 h, and
processed for immunofluorescence microscopy. FACS anal-
ysis of cell samples was done at each time point . As shown
in Fig . 11, FACS analysis indicated that cells proceeded
through the cell cycle after removal of hydroxyurea . More
than 500 cells were counted in continuous microscopic fields
of each sample for nuclear positive cells by Ab 276 to detect
changes of CKII a' in nucleus during cell cycle (Figs . 12 and
13) . The percent of nuclear-positive cells in asynchronous
cells increased from 86.4 t 0.3% (Figs . 11 A ; 12, A and B;
and 13, closed triangle) to 94.7 f 1.7% (Figs . 11 B, 12 C
and D, and 13, open triangles) by the hydroxyurea arrest . Af-
ter removal of hydroxyurea, cellsbecome less nuclear posi-
tive (60.7 t 3.3% ; Fig . 12, E and F), and progress into S
phase (Fig . 11 C) . At 8 h, most cells are in G2/M phase
(Figs . 11D and 12, GandH) . The cells are back to Gl phase
at 12 h, maintaining up to 24 h, and are mostly nuclear posi-
tive (Figs . 11, E-H; 12, I and J to O and P; and 13, open
triangles) . These results further indicate the regulation of
CKII a' localization during the cell cycle.
Discussion
In this report, we describe our investigations of the distribu-
tion of CKII in interphase and mitotic HeLa cells . Our
findings of CKII a, a', and ß subunit localization by im-
munohistochemistry support the concept that CKII is regu-
latedby transport between the cytoplasm and nucleus during
the cell division cycle .
The localization studies indicated that the CKII a subunit,
which is a catalytic subunit of the kinase, is localized to the
cytoplasm throughout interphase. One ofthe functions of the
CKII a subunit in mitotic and postmitotic cells might involve
regulating the organization of the cytoskeleton . Both di-
viding cells and postmitotic cells undergo morphological
changes that depend on the arrangement of the cytoskeleton .
For example, mitotic cellsbecome rounded and release from
the substrate. After mitosis, cells reattach to the substrate
and flatten out . In addition, postmitotic cells, such as neu-
rons and macrophages, continue to reorganize the cytoskele-
ton to differentiate and maintain cellular functions (Mitchi-
son and Kirschner, 1988 ; Didier et al., 1989) . CKII a may
be involved in this cytoskeletal reorganization by phosphory-
lation of protein components such as tubulin and myosin.
Nonmuscle bovine brain myosin heavy chain can be phos-
phorylated by CKII, although the functional importance of
the phosphorylation is not known (Murakami et al., 1990) .
Tubulin and microtubule-associated proteins also have been
shown to be phosphorylated by CKII (Serrano et al., 1987;
Diaz-Nido et al., 1990a,b), and endogenous CKII-like ac-
tivity has been found in purified brain microtubule proteins
(Serrano et al., 1987, 1989) . The 68 K neurofilament pro-
tein also has a CKII site in its carboxy terminus (Lewis and
Cowan, 1985), and there may be many other, yet unidenti-
fied, cytoskeletal proteins that are phosphorylated and regu-
lated by CKII .
The ß subunit of CKII showed a staining pattern similar
1227Figure 12. Immunofluorescence
in hydroxyurea arrest released
HeLa cells. HeLa cellsgrownon
12-mm coverslips in 24-well tis-
sue culture dishes were treated
with hydroxyurea for 14 h, then
the cells were washed and in-
cubated with newmedium. HeLa
cellswere stained as described in
Materialsand Methods using Ab
276; A and B, asynchronous
HeLa cells; CandD, 0hafter re-
lease; E and F, 4 h ; G and H, 8
h; 1and J, 12 h; K and L, 16 h;
Mand N, 20 h; O and P, 24 h .
Bar, 20 Am .Yu et al . Immunocytochemical Localization of Casein Kinase 11
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Figure 13 . Percent of nuclear
positive of hydroxyurea arrest
released HeLa cells. Asynchro-
nous HeLa cells (closed tri-
angle) arrested by hydroxyurea
for 14 h were washed and in-
cubated with new medium.
Samples were taken at 0, 4, 8,
12, 16, 20, and 24 h (open tri-
angles) and processed for im-
munofluorescence microscopic
evaluation . More than 500
cells were counted for the nu-
clear positive in continuous
microscopic fields .
to that of CKII a . The CKII ß subunit is mainly localized
to the cytoplasm and to a much lesser degree in the nucleus
of interphase cells. The function of theß subunit is not well
understood, but it appears to have a regulatory role in the
holoenzyme (Takio et al ., 1987; Ackerman et al., 1990 ; Hu
and Rubin, 1990b) . No similarity has been found to any
known proteins or protein sequences inferred from DNA se-
quences (Jakobi et al., 1989) . The co-localization of the a
and ß subunits demonstrated here further supports the postu-
late thatthe ß subunit is required for optimal activity ofCKII
holoenzyme and perhaps for regulation ofthe CKIIa subunit
(Cochet and Chambaz, 1983 ; Ackerman et al., 1990) . One
property of theß subunit is that overexpression of itscDNA
in xeroderma pigmentosa fibroblasts makes the cells par-
tially resistant to ultraviolet radiation (Teitz et al ., 1990) .
This finding implies that the ß subunit may have a function
inDNA repair mechanisms, further emphasizing the need to
characterize nuclear forms of CKII subunits .
The a' subunit of CKII showed a very different staining
pattern compared to a and ß subunits . The antibodies 247
and 276 that react with both a and a' subunits have provided
useful information when interpreted with the data on the a
subunit . It is likely that a' is the nuclear form of CKII, as
suggested by the consistent presence of a in the cytoplasm
rather than in the nucleus, and the nuclear staining pattern
ofAbs 247 and 276 which recognize both a and a'. Alterna-
tively, the nuclear (a) formmay be present in different com-
plexes so the epitopes are not immunoreactive. However,
Abs 247 and 276 recognize distinct epitopes on the mole-
cule, strengthening ourproposal that the differential staining
represents true localization rather than differential immuno-
reactivity of protein complexes .
The immunocytochemical observations ofBelenguer et al .
(1989) and Filhol et al . (1990), showed reduced staining of
confluent cells and an increased concentration ofCKII in the
nucleus ofproliferating cells . Confluent bovine adrenocorti-
cal cells showed the presence of CKII in the cytoplasm and
an absence of nuclear CKII, while actively growing cells
showed the predominant CKII concentration in nuclei (Fil-
hol et al ., 1990) . In confluent bovine aortic endothelial cells,
CKII was barely detected in either the cytoplasm or the nu-
cleus, while it was prominent in both the nucleus and the
cytoplasm of exponentially growing cells (Belenguer et al.,
1989) . These variabilities in nuclear staining using antibod-
ies against holoenzyme observed by those authors may be
due to the movement or disintegration of CKII a' from the
nucleus in specific cell cycle stages. The different results may
be due to the difference of their Ab's subunit specificity, of
species, of cell type, or of cell culture stages such as Go vs
G1 , or quiescent vs arrested . Our data demonstrated that
the major translocatable subunit of the enzyme in the nu-
cleus ofhuman cells is CKII a' . The activity of CKII is lower
at S phase (Carroll, D., andD. R . Marshak, manuscript sub-
mitted for publication) or Go phase of cell cycle. Stimula-
tion by serum or growth factors induces an,enhanced activa-
tion of CKII (Carroll and Marshak, 1989) . If the activation
ofCKII and translocation ofCKII from cytoplasm to nucleus
are a prerequisite for cell proliferation and onset of the cell
cycle, the migration of CKII a' from the cytoplasm to the nu-
cleus at G, and from the nucleus to the cytoplasm at S must
be one ofthe important regulation steps ofcell cycle control .
The nuclear form of the CKII a' subunit may not require
the ß subunit for its optimal activity or regulation in inter-
phase cells . It seems possible, therefore, that the nuclear
form ofCKIImay have a distinct physiological role from that
of the a subunit . Notably, the ß subunit is the site of auto-
phosphorylation and, therefore, the a' subunit may be regu-
lated by other means . The significance of a' in the cell cycle
has been studied in the budding yeast, Saccharomyces
cerevisiae (Padmanabha et al ., 1990) . Null mutations of the
CKA1 (a) gene do not confer a detectable phenotype, and
haploid cells in which the CKA2 (a) gene alone is disrupted
show no detectablephenotype. However, haploid cells carry-
ing disruptions in both the CKA1 andCKA2 genes are invia-
ble, and exhibit growth arrest (Padmanabha et al ., 1990) .
Cell cycle control ofCKII activity in mammalian cells (Car-
roll, D., I . J. Yu, and D. R . Marshak, manuscript submitted
for publication) might be regulated by the translocation
phenomenon described here or by an endogenous inhibitor
compound . The most distinct characteristic of the CKII a'
subunit appears to be the regulation ofits localization during
the cell cycle .
As shown here, a small number (ti20%) of cells are nu-
cleus negative withAb 276. CKII isknown to phosphorylate
numerous nuclear proteins in addition to cytoplasmic pro-
teins (Edelman et al ., 1987) . The presence of the CKII a'
subunit in the nucleus rather than the CKII a subunit, sug-
gests that the CKII a subunit may play a significant role in
regulation of such processes as DNA replication, transcrip-
tion, and nuclear and nucleolar reorganization . It further im-
plies that signal transduction pathways from the cytoplasm
to the nucleus by CKII are rather complicated . The advan-
tages to the cell ofutilizing the CKII a' subunit in the nucleus
are not known at this time . The different properties may be
provided by the carboxy terminus of the two polypeptides,
since this is the region of vast sequence heterogeneity (Loze-
man et al., 1990) . Absence of carboxy-terminal structures
(ti40 amino acids) in a' might provide a different means of
regulatory transport of CKII across the nuclear envelope .
Alternatively, the absence ofthese sequences may elevate the
effect of the putative nuclear localization sequence that is
recognized by Ab 247 and is essential for the inhibition
mediated by polyanionic compounds, such as heparin (Hu
and Rubin, 1990b) . Furthermore, the absence of these se-
quences may inhibit association of the ß subunit, and thus
result in a different level of regulation .
The absence of CKII a, a', and ß subunits from the nu-
cleus in some percentage of cells implies that there is a short
1230period in the nucleus when CKII is not required or is present
as another form, which is not detected by conventional chro-
matography or by our immunological reagents. The regula-
tion of the presence and absence of CKII a' in the nucleus
during such critical phases is in need offurther investigation.
In summary, our current working model of CKII localiza-
tion in the cell cycle is as follows. During the G, phase of
the cell cycle in proliferating cells, CKII activity is high, and
the a and ß subunits remain cytoplasmic, while the «'
subunit exists as the nuclear form. At the S phase of cell cy-
cle, the a' subunit translocates from the nucleus to the
cytoplasm concomitant with a decrease in CKII activity.
When cells reach mitosis and the nuclear envelope breaks
down, all forms of the enzyme are diffusely distributed
throughout the cell and are also associated with spindle
fibers. The role ofCKII in cell growth appear to be complex,
with certain forms associated with cytoplasmic structures
and other forms (a) associated with the nucleus. The studies
presented here contribute to a greater understanding of the
function of CKII subunits in the control of cell growth.
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